Jump to ContentJump to Main Navigation
Show Summary Details

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board Member: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Sies, Helmut / Turk, Boris / Wittinghofer, Alfred


SCImago Journal Rank (SJR) 2015: 1.607
Source Normalized Impact per Paper (SNIP) 2015: 0.751
Impact per Publication (IPP) 2015: 2.609

249,00 € / $374.00 / £187.00*

Online
ISSN
1437-4315
See all formats and pricing

 


 
 

Select Volume and Issue
Loading journal volume and issue information...

30,00 € / $42.00 / £23.00

Get Access to Full Text

The Btk inhibitor LFM-A13 is a potent inhibitor of Jak2 kinase activity

E. van den Akker / T.B. van Dijk / U. Schmidt / L. Felida / H. Beug / B. Löwenberg / M. von Lindern

Citation Information: Biological Chemistry. Volume 385, Issue 5, Pages 409–413, ISSN (Print) 1431-6730, DOI: 10.1515/BC.2004.045, June 2005

Publication History

Published Online:
2005-06-01

Abstract

LFMA13, or α-cyano-β-hydroxy-β-methyl-N-(2,5-dibromophenyl)propenamide, was shown to inhibit Brutons tyrosine kinase (Btk). Here we show that LFM-A13 efficiently inhibits erythropoietin (Epo)-induced phosphorylation of the erythropoietin receptor, Janus kinase 2 (Jak2) and downstream signalling molecules. However, the tyrosine kinase activity of immunoprecipitated or in vitro translated Btk and Jak2 was equally inhibited by LFM-A13 in in vitro kinase assays. Finally, Epo-induced signal transduction was also inhibited in cells lacking Btk. Taken together, we conclude that LFM-A13 is a potent inhibitor of Jak2 and cannot be used as a specific tyrosine kinase inhibitor to study the role of Btk in Jak2-dependent cytokine signalling.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
L. Vargas, A. Hamasy, B. F. Nore, and C. I. E. Smith
Scandinavian Journal of Immunology, 2013, Volume 78, Number 2, Page 130
[2]
Hélène Munier-Lehmann, Pierre-Olivier Vidalain, Frédéric Tangy, and Yves L. Janin
Journal of Medicinal Chemistry, 2013, Volume 56, Number 8, Page 3148
[3]
Joseph J. Buggy and Laurence Elias
International Reviews of Immunology, 2012, Volume 31, Number 2, Page 119
[5]
Thomas U. Marron, Monica Martinez-Gallo, Joyce E. Yu, and Charlotte Cunningham-Rundles
Journal of Allergy and Clinical Immunology, 2012, Volume 129, Number 1, Page 184
[6]
Róbert Kiss, Tímea Polgár, Annet Kirabo, Jacqueline Sayyah, Nicholas C. Figueroa, Alan F. List, Lubomir Sokol, Kenneth S. Zuckerman, Meghanath Gali, Kirpal S. Bisht, Peter P. Sayeski, and György M. Keserű
Bioorganic & Medicinal Chemistry Letters, 2009, Volume 19, Number 13, Page 3598
[7]
Gemma Triola, Stefan Wetzel, Bernhard Ellinger, Marcus A. Koch, Katja Hübel, Daniel Rauh, and Herbert Waldmann
Bioorganic & Medicinal Chemistry, 2009, Volume 17, Number 3, Page 1079
[8]
Maria E. Nelson and David P. Steensma
Leukemia & Lymphoma, 2006, Volume 47, Number 2, Page 177
[9]
Douglas J. Marcotte, Yu-Ting Liu, Robert M. Arduini, Catherine A. Hession, Konrad Miatkowski, Craig P. Wildes, Patrick F. Cullen, Victor Hong, Brian T. Hopkins, Elisabeth Mertsching, Tracy J. Jenkins, Michael J. Romanowski, Darren P. Baker, and Laura F. Silvian
Protein Science, 2010, Page NA
[10]
C. D. Palmer, B. E. Mutch, S. Workman, J. P. McDaid, N. J. Horwood, and B. M. J. Foxwell
Blood, 2008, Volume 111, Number 4, Page 1781
[11]
Merav Socolovsky
Current Opinion in Hematology, 2007, Volume 14, Number 3, Page 215
[12]
M. G. Nair, Y. Du, J. G. Perrigoue, C. Zaph, J. J. Taylor, M. Goldschmidt, G. P. Swain, G. D. Yancopoulos, D. M. Valenzuela, A. Murphy, M. Karow, S. Stevens, E. J. Pearce, and D. Artis
Journal of Experimental Medicine, 2009, Volume 206, Number 4, Page 937
[13]
C.R. Shideman, S. Hu, P.K. Peterson, and S.A. Thayer
Journal of Neuroscience Research, 2006, Volume 83, Number 8, Page 1471
[14]
Ayalew Tefferi, Terra L. Lasho, Susan M. Schwager, David P. Steensma, Ruben A. Mesa, Chin-Yang Li, Martha Wadleigh, and D. Gary Gilliland
British Journal of Haematology, 2005, Volume 131, Number 3, Page 320

Comments (0)

Please log in or register to comment.